{"id":"rhb-102","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-15%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inhibiting the action of ghrelin, a hormone that stimulates appetite and gastric contractions, thereby reducing nausea and vomiting.","oneSentence":"RHB-102 is a gastric motility agent.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:32:05.934Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Nausea and vomiting associated with chemotherapy"}]},"trialDetails":[{"nctId":"NCT02246439","phase":"PHASE3","title":"BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2014-12-08","conditions":"Gastroenteritis, Gastritis","enrollment":330},{"nctId":"NCT02757105","phase":"PHASE2","title":"Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2016-05-19","conditions":"Irritable Bowel Syndrome With Diarrhea","enrollment":127}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"RHB-102","genericName":"RHB-102","companyName":"RedHill Biopharma Limited","companyId":"redhill-biopharma-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"RHB-102 is a gastric motility agent. Used for Nausea and vomiting associated with chemotherapy.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}